ArticleLipids in health and disease2025
Joint analysis of atherogenic index of plasma clusters and a body shape index trajectories in incident stroke risk.
Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAs emerging biomarkers for stroke risk, the clinical value of the atherogenic index of plasma and a body shape index has gained increasing attention. However, current research on their combined use for stroke risk stratification remains limited. This study aims to analyze the combined effects of Atherogenic Index of Plasma (AIP) and A Body Shape Index (ABSI) trajectories to explore their potential contribution to improving stroke risk prediction accuracy.
methodsThe study data were derived from the China Health and Retirement Longitudinal Study conducted between 2011 and 2018, ultimately including 4,942 participants with two AIP measurements and three ABSI measurements collected for each participant. AIP was classified using K-means clustering analysis, and cumulative AIP values were calculated. The latent class trajectory model was employed to identify characteristic ABSI trajectory patterns over time. Cox proportional hazards models were used to calculate hazard ratios (HRs) with 95% confidence intervals (95% CIs).
resultsThe median follow-up duration in China Health and Retirement Longitudinal Study (CHARLS) was 3.0 years, during which 395 of 4,942 participants (7.99%) developed stroke. Adjusted multivariable Cox regression models demonstrated that both the high AIP clustering combined with high ABSI trajectory model (HR = 2.256, 95% CI: 1.346-3.781, P = 0.002) and the high cumulative AIP with high ABSI trajectory model (HR = 2.455, 95% CI: 1.514-3.983, P < 0.001) showed significant associations with stroke in their respective groups, with both associations remaining robust in sensitivity analyses. The AIP clustering combined with ABSI trajectory model exhibited the highest diagnostic performance for stroke (area under the receiver operating characteristic curve [AUC]: 0.612).
conclusionThe combined prediction of AIP and ABSI enables earlier identification of stroke risk in the general population, demonstrating significant clinical value for stroke prevention and treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.